Company Filing History:
Years Active: 2020-2025
Title: Fernando Dangond: Innovator in Multiple Sclerosis Treatment
Introduction
Fernando Dangond is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of progressive forms of multiple sclerosis. With a total of 2 patents, his work focuses on innovative oral dosing regimens that can improve patient outcomes.
Latest Patents
Dangond's latest patents include a regimen involving Cladribine for treating progressive forms of multiple sclerosis. His research emphasizes specific oral dosings, dosage forms, and dose regimens that can be effective for conditions such as Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis. These methods aim to enhance the efficacy of Cladribine in treating these challenging forms of the disease.
Career Highlights
Throughout his career, Fernando Dangond has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Ares Trading S.A. His experience in these organizations has contributed to his expertise in developing innovative treatment methods.
Collaborations
One of his notable collaborators is Matthias Dotzauer, with whom he has worked on various projects related to his patents and research.
Conclusion
Fernando Dangond's contributions to the treatment of multiple sclerosis through innovative oral dosing regimens highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in patient care and treatment options.